Small Airways Disease (SAD) in Severe Asthma as a Novel Endpoint and Distinct Target for Mepolizumab (SASAM Study)
Condition(s):Small Airway Disease; AsthmaLast Updated:September 10, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Small Airway Disease; AsthmaLast Updated:September 10, 2021Unknown status
Condition(s):COPDLast Updated:November 14, 2023Completed
Condition(s):Asthma; Small Airway DiseaseLast Updated:May 6, 2020Unknown status
Condition(s):COPD; Small Airway DiseaseLast Updated:May 12, 2020Unknown status
Condition(s):AsthmaLast Updated:June 28, 2013Completed
Condition(s):AsthmaLast Updated:January 4, 2023Recruiting
Condition(s):Small Airway Disease; AsthmaLast Updated:March 31, 2023Recruiting
Condition(s):COPDLast Updated:January 25, 2024Not yet recruiting
Condition(s):Pulmonary Disease, Chronic Obstructive; Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome; Small Airway Disease; Quality of LifeLast Updated:June 27, 2018Unknown status
Condition(s):COPD; Emphysema; Small Airway DiseaseLast Updated:July 30, 2013Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.